Introduction: Who Should Undergo Breast Cancer Diagnostics

Breast cancer diagnostics are important for all women, particularly those who notice changes in their breasts or reach certain ages. Women age 50 and older should be especially attentive to breast health, as this group experiences higher rates of breast cancer diagnoses. However, younger women and even men can develop breast cancer, so staying aware of symptoms matters at any age.^[1]

You should seek diagnostic testing if you notice any unusual changes in your breasts. These changes might include finding a new lump or thickening that feels different from the surrounding tissue. The lump may feel as small as a pea, or you might notice a larger mass. Changes in breast size, shape, or contour also warrant medical attention. Sometimes the skin on your breast or nipple looks different—it might appear dimpled, puckered, scaly, or inflamed. The skin could also turn red, purple, or darker than other areas of your breast.^[1]

Even without obvious symptoms, regular screening serves as a cornerstone of early detection. In Western countries, most breast cancers are now discovered through routine screening programs rather than because someone felt a lump or experienced symptoms. This shift has allowed doctors to find cancers earlier, when they are more treatable.^[5]

People with certain risk factors may need to start diagnostic screening earlier or more frequently. A family history of breast cancer, especially in close relatives like a mother or sister, increases your risk. Those who have tested positive for gene mutations such as BRCA1 or BRCA2—which are genetic changes that significantly raise breast cancer risk—should discuss appropriate screening schedules with their doctors.^[5]

Roughly half of all breast cancers occur in women who have no specific risk factors other than being female and getting older. This means that even if you feel healthy and have no family history, regular screening remains important. Female gender alone is the strongest risk factor for breast cancer, with approximately 99% of cases occurring in women and only about 0.5 to 1% occurring in men.^[4]

Classic Diagnostic Methods for Breast Cancer

Healthcare providers use several established methods to diagnose breast cancer and distinguish it from other breast conditions. The diagnostic process typically begins with a physical examination and progresses through imaging tests and, when necessary, tissue sampling.

Clinical Breast Examination

A clinical breast exam is often the first step in breast cancer diagnosis. During this examination, a healthcare professional carefully looks at your breasts to spot anything unusual, such as changes in skin texture or appearance of the nipple. The provider then uses their hands to feel the breast tissue for lumps or areas of thickening. They also check the areas along your collarbones and under your arms, where lymph nodes—small bean-shaped structures that filter fluid and help fight infection—are located. If cancer has spread, it often travels first to nearby lymph nodes.^[8]

Mammography

Mammograms are X-ray images of breast tissue and represent one of the most common and important screening tools for breast cancer. During a mammogram, a technician positions your breast on a flat platform. Another platform then presses down on your breast from above to flatten the tissue, which helps create a clearer image. While this compression can feel uncomfortable, it only lasts for a few moments. The X-ray machine then takes images from different angles.^[8]

Mammograms can detect breast cancers that are too small to feel during a physical exam. They can also reveal calcifications—tiny deposits of calcium in breast tissue—which sometimes indicate the presence of cancer cells. If a screening mammogram shows something concerning, your doctor may order additional imaging tests to get a better look at the suspicious area.^[8]

Breast Ultrasound

Breast ultrasound uses sound waves to create images of breast tissue. This test is particularly helpful for examining lumps or abnormalities found during a mammogram or physical exam. Ultrasound can often tell the difference between a fluid-filled cyst—a sac containing liquid that is usually not cancerous—and a solid mass that might be cancer. Unlike mammograms, ultrasound does not use radiation, which makes it safe for younger women and pregnant women.^[8]

Breast MRI

A breast MRI (magnetic resonance imaging) uses magnets and radio waves instead of X-rays to create detailed pictures of breast tissue. During this test, you lie face down on a padded table with spaces designed to accommodate your breasts. The table then slides into a large tube-shaped machine. An MRI provides much more detailed images than a mammogram and can sometimes detect cancers that other tests miss.^[8]

Doctors typically reserve MRI for specific situations rather than routine screening. Women at very high risk for breast cancer, such as those with BRCA gene mutations, may benefit from MRI screening in addition to mammograms. MRI is also useful when doctors need to determine the exact size of a known cancer or check whether it has spread to other areas of the breast.

Breast Biopsy

When imaging tests reveal a suspicious area, a biopsy confirms whether cancer is present. During a biopsy, a doctor removes a small sample of tissue from the suspicious area. A specialist called a pathologist then examines this tissue under a microscope to look for cancer cells.^[8]

Several types of biopsies exist. A core needle biopsy uses a hollow needle to remove a cylinder-shaped sample of tissue. This type of biopsy can often be performed in a doctor’s office with local numbing medicine. The needle is guided to the right spot using ultrasound or mammogram imaging. In some cases, doctors perform a surgical biopsy, which involves making a small cut in the breast to remove tissue. The type of biopsy your doctor recommends depends on where the suspicious area is located and how large it is.^[8]

Laboratory Analysis of Tissue

Once tissue is obtained through biopsy, laboratory testing reveals critical information about the cancer. Pathologists examine the cells to confirm the presence of cancer and determine what type it is. Most breast cancers start in the milk ducts and are called ductal carcinoma. Cancer that begins in the milk-producing glands, called lobules, is known as lobular carcinoma.^[9]

The laboratory also tests whether the cancer cells have certain proteins on their surface called receptors. Some breast cancer cells have receptors that attract hormones like estrogen and progesterone. When hormones attach to these receptors, they can help the cancer grow. Testing for hormone receptors helps doctors determine which treatments will work best. Cancers with estrogen receptors are called ER-positive, while those with progesterone receptors are PR-positive.^[1]

Another important test checks for a protein called HER2. Some breast cancers have higher than normal levels of HER2 protein, which helps cancer cells grow quickly. About 15 to 20% of breast cancers are HER2-positive. Knowing the HER2 status helps doctors choose targeted treatments that specifically work against HER2-positive cancers.^[1]

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments for breast cancer. When patients consider joining a clinical trial, they must undergo specific tests to determine if they meet the trial’s requirements. These requirements, called eligibility criteria, help researchers ensure the trial is safe for participants and that the results will be meaningful.

The diagnostic tests needed for clinical trial enrollment build upon the standard tests used for breast cancer diagnosis. Researchers need detailed information about your cancer’s characteristics, stage, and how it has responded to any previous treatments. Most trials require confirmation that you actually have breast cancer through biopsy results examined by a pathologist.^[9]

Many clinical trials focus on specific types or subtypes of breast cancer. For example, a trial might only accept patients with triple-negative breast cancer, a type that lacks estrogen receptors, progesterone receptors, and HER2 protein. To qualify for such a trial, you would need laboratory test results confirming your cancer is triple-negative. Other trials might specifically target HER2-positive cancers, requiring proof that your tumor has elevated HER2 levels.

Blood tests often play a role in clinical trial qualification. Researchers need to verify that your organs, especially your liver and kidneys, are functioning well enough to handle the trial treatment. Blood cell counts must fall within acceptable ranges to ensure your bone marrow can produce enough blood cells. These tests include measuring red blood cells, white blood cells, and platelets—cells that help blood clot.

Imaging tests help researchers understand the extent of your cancer. A trial might require CT scans, MRI, or other imaging to measure the size of tumors and check whether cancer has spread to lymph nodes or other organs. These baseline images allow researchers to compare later images and determine if the treatment is working. Some trials use specialized imaging techniques, such as PET scans, which show how tissues use sugar and can help identify active cancer cells.

Heart function tests may be required for trials testing treatments that can affect the heart. An electrocardiogram (ECG or EKG) records the electrical activity of your heart, while an echocardiogram uses sound waves to create moving pictures of your heart. These tests ensure your heart is strong enough for the trial treatment.

Some clinical trials require genetic testing to identify specific mutations or changes in your cancer cells. This testing looks deeper than the standard hormone receptor and HER2 tests. Researchers might search for particular genetic alterations that the trial treatment is designed to target. For instance, a trial might focus on cancers with mutations in genes that control how cells repair damaged DNA.

Clinical trials may also require documentation of your complete medical history, including any previous cancer treatments you received and how your cancer responded. If you have received chemotherapy, hormone therapy, or other treatments before, researchers need to know which ones, how much you received, and whether they helped shrink the cancer or stop its growth.

The specific diagnostic requirements vary widely between different clinical trials. Some trials accept patients newly diagnosed with early-stage breast cancer who have not yet started treatment. Others specifically look for patients whose cancer has spread to distant parts of the body, a situation called metastatic breast cancer. Still other trials enroll patients whose cancer has returned after treatment or has stopped responding to standard therapies.

Before joining a clinical trial, you will meet with the research team who will explain all the tests required and help you understand why each one is necessary. These qualification tests protect your safety by ensuring the trial is appropriate for your specific situation and that you are healthy enough to participate. While the extra testing might seem burdensome, it helps researchers develop better treatments that could benefit future patients with breast cancer.